Treatment-Resistant Depression: What is the role of Ketamine, DBS, VNS, TMS, and Psychedelics? Special Guest Dr. Scott Aaronson New Perceptions

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Treatment-Resistant Depression with Special Guest and Psychiatrist Dr. Scott Aaronson.

Dr. Scott Aaronson obtained his M.D. from Harvard University in 1981. He is currently an Associate Professor at The University of Maryland School of Medicine, a Distinguished Life Fellow of the American Psychiatric Association, a Fellow of The American College of Psychiatrists. He serves on the board of the American Society of Clinical Psychopharmacology and the board of the Clinical TMS Society. He currently is the Director of Clinical Research for The Retreat at Sheppard Pratt.

Referenced Articles on Treatment-Resistant Depression:

https://www.ncbi.nlm.nih.gov/pubmed/30974339

https://journals.sagepub.com/doi/abs/10.1177/0004867418808585?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=anpa

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/


---

Support this podcast: https://podcasters.spotify.com/pod/show/journalofpsychedelic/support